Target Name: MIR4251
NCBI ID: G100422968
Other Name(s): hsa-miR-4251 | microRNA 4251 | MicroRNA 4251 | hsa-mir-4251

MIR4251: A Drug Target / Disease Biomarker

MIR4251, also known as interleukin-4 dependent gene 41, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

MIR4251 is a part of the interleukin-4 gene family, which is known for its role in the regulation of immune and inflammatory responses. The interleukin-4 gene family has been implicated in the development and progression of many diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

MIR4251 is expressed in a variety of tissues and cells, including immune cells, neurons, and tissues. It has been shown to play a role in the regulation of immune responses, cell survival, and cell cycle progression.

One of the most promising aspects of MIR4251 is its potential as a drug target. MIR4251 has been shown to interact with several protein molecules, including the transcription factor STAT3. This interaction suggests that MIR4251 may be a useful target for drugs that are designed to inhibit the activity of STAT3.

In addition to its potential as a drug target, MIR4251 has also been identified as a potential biomarker for several diseases. For example, MIR4251 has been shown to be downregulated in a variety of cancer tissues, and it has been proposed as a potential biomarker for cancer. Similarly, MIR4251 has been shown to be elevated in the brains of individuals with Alzheimer's disease, and it has been proposed as a potential biomarker for this disease.

Another promising aspect of MIR4251 is its role in the regulation of cell cycle progression. MIR4251 has been shown to play a role in the regulation of the G1 phase of the cell cycle, which is important for cell growth and division. This suggests that MIR4251 may be a useful target for drugs that are designed to inhibit cell cycle progression.

In conclusion, MIR4251 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases. Its interaction with the transcription factor STAT3 and its role in the regulation of immune responses, cell survival, and cell cycle progression make it a promising target for drugs that are designed to inhibit its activity. Further research is needed to fully understand the potential of MIR4251 as a drug and biomarker.

Protein Name: MicroRNA 4251

More Common Targets

MIR4252 | MIR4253 | MIR4254 | MIR4255 | MIR4256 | MIR4257 | MIR4258 | MIR4259 | MIR4260 | MIR4261 | MIR4262 | MIR4263 | MIR4264 | MIR4265 | MIR4266 | MIR4267 | MIR4268 | MIR4269 | MIR4270 | MIR4271 | MIR4272 | MIR4273 | MIR4274 | MIR4275 | MIR4276 | MIR4277 | MIR4278 | MIR4279 | MIR4280 | MIR4281 | MIR4282 | MIR4283-1 | MIR4283-2 | MIR4284 | MIR4285 | MIR4286 | MIR4287 | MIR4288 | MIR4289 | MIR429 | MIR4290 | MIR4291 | MIR4292 | MIR4293 | MIR4294 | MIR4295 | MIR4296 | MIR4297 | MIR4298 | MIR4299 | MIR4300 | MIR4300HG | MIR4301 | MIR4302 | MIR4303 | MIR4304 | MIR4305 | MIR4306 | MIR4307 | MIR4308 | MIR4309 | MIR431 | MIR4310 | MIR4311 | MIR4312 | MIR4313 | MIR4314 | MIR4315-1 | MIR4315-2 | MIR4316 | MIR4317 | MIR4318 | MIR4319 | MIR432 | MIR4320 | MIR4321 | MIR4322 | MIR4323 | MIR4324 | MIR4325 | MIR4326 | MIR4327 | MIR4328 | MIR4329 | MIR433 | MIR4330 | MIR4418 | MIR4420 | MIR4423 | MIR4425 | MIR4427 | MIR4428 | MIR4429 | MIR4430 | MIR4431 | MIR4432 | MIR4432HG | MIR4433A | MIR4433B | MIR4435-1